Completed
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
NCT02538705
- Conditions
- Pathologic Processes, Pathological Conditions, Signs and Symptoms, Ulcer, +1 more
- Locations
-
- Human Stem Cell Institute Moscow, Russia